Verano Holdings (VRNO) Return on Invested Capital (2022 - 2026)
Verano Holdings (VRNO) posted quarterly Return on Invested Capital of 0.4% for Q1 2026, down 36.0% year-over-year from 0.62% in Q1 2025, and down 215.24% quarter-over-quarter from 0.13% in Q4 2025.
Verano Holdings (VRNO) Return on Invested Capital (2022 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Return on Invested Capital for 5 consecutive years, with 0.4% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Invested Capital fell 36.0% year-over-year to 0.4%; the TTM figure through Mar 2026 stood at 0.4% (down 36.0% YoY), while the FY2025 annual figure was 0.18%, up 6.0% from the prior year.
- Return on Invested Capital eased to 0.4% in Q1 2026 per VRNO's latest filing, from 0.13% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.06% in Q3 2024 and bottomed at 0.4% in Q1 2026.
- Historically, Return on Invested Capital has averaged 0.06% across 5 years, with a median of 0.03% in 2024.
- Annual changes were most pronounced in 2024 — Return on Invested Capital grew 8 bps — and 2026, when it sank 36 bps.
- Verano Holdings' Return on Invested Capital stood at 0.01% in 2022, then tumbled by 1042 bps to 0.06% in 2023, then soared by 53 bps to 0.03% in 2024, then sank by 322 bps to 0.13% in 2025, then plunged by 215 bps to 0.4% in 2026.
- Business Quant data shows VRNO's Return on Invested Capital at 0.4% in Q1 2026, 0.13% in Q4 2025, and 0.09% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Verano Holdings | 440.28 Mn | 355.08 Mn | 99.70 Mn | -0.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.06% |
| Mar 31, 2026 | -0.40% |
| Dec 31, 2025 | -0.13% |
| Sep 30, 2025 | -0.09% |
| Jun 30, 2025 | -0.07% |
| Mar 31, 2025 | -0.04% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | 0.06% |
| Jun 30, 2024 | -0.12% |
| Mar 31, 2024 | -0.08% |
| Dec 31, 2023 | -0.06% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |